OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $464,992 Invested

2014

St George's University of London

Atticus Hainsworth, PhD

Repurposing the PDE5 inhibitor tadalafil for vascular cognitive impairment. A test of concept in older people

  • Funding Amount: $464,992
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Vascular
  • Status: Closed